1497 related articles for article (PubMed ID: 11955436)
1. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism.
Liu C; Li Y; Semenov M; Han C; Baeg GH; Tan Y; Zhang Z; Lin X; He X
Cell; 2002 Mar; 108(6):837-47. PubMed ID: 11955436
[TBL] [Abstract][Full Text] [Related]
2. Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification.
Farr GH; Ferkey DM; Yost C; Pierce SB; Weaver C; Kimelman D
J Cell Biol; 2000 Feb; 148(4):691-702. PubMed ID: 10684251
[TBL] [Abstract][Full Text] [Related]
3. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A
EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734
[TBL] [Abstract][Full Text] [Related]
4. Biochemical characterization of the Drosophila wingless signaling pathway based on RNA interference.
Matsubayashi H; Sese S; Lee JS; Shirakawa T; Iwatsubo T; Tomita T; Yanagawa S
Mol Cell Biol; 2004 Mar; 24(5):2012-24. PubMed ID: 14966281
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Wnt signaling by Axin and Axil.
Kikuchi A
Cytokine Growth Factor Rev; 1999; 10(3-4):255-65. PubMed ID: 10647780
[TBL] [Abstract][Full Text] [Related]
6. Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex.
Willert K; Shibamoto S; Nusse R
Genes Dev; 1999 Jul; 13(14):1768-73. PubMed ID: 10421629
[TBL] [Abstract][Full Text] [Related]
7. Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3beta and beta-catenin and inhibits axis formation of Xenopus embryos.
Yamamoto H; Kishida S; Uochi T; Ikeda S; Koyama S; Asashima M; Kikuchi A
Mol Cell Biol; 1998 May; 18(5):2867-75. PubMed ID: 9566905
[TBL] [Abstract][Full Text] [Related]
8. Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization.
Fagotto F; Jho Eh; Zeng L; Kurth T; Joos T; Kaufmann C; Costantini F
J Cell Biol; 1999 May; 145(4):741-56. PubMed ID: 10330403
[TBL] [Abstract][Full Text] [Related]
9. New steps in the Wnt/beta-catenin signal transduction pathway.
Sakanaka C; Sun TQ; Williams LT
Recent Prog Horm Res; 2000; 55():225-36. PubMed ID: 11036939
[TBL] [Abstract][Full Text] [Related]
10. Regulation of glycogen synthase kinase 3beta and downstream Wnt signaling by axin.
Hedgepeth CM; Deardorff MA; Rankin K; Klein PS
Mol Cell Biol; 1999 Oct; 19(10):7147-57. PubMed ID: 10490650
[TBL] [Abstract][Full Text] [Related]
11. Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway.
Amit S; Hatzubai A; Birman Y; Andersen JS; Ben-Shushan E; Mann M; Ben-Neriah Y; Alkalay I
Genes Dev; 2002 May; 16(9):1066-76. PubMed ID: 12000790
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation.
Ha NC; Tonozuka T; Stamos JL; Choi HJ; Weis WI
Mol Cell; 2004 Aug; 15(4):511-21. PubMed ID: 15327768
[TBL] [Abstract][Full Text] [Related]
13. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta.
Behrens J; Jerchow BA; Würtele M; Grimm J; Asbrand C; Wirtz R; Kühl M; Wedlich D; Birchmeier W
Science; 1998 Apr; 280(5363):596-9. PubMed ID: 9554852
[TBL] [Abstract][Full Text] [Related]
14. Dapper, a Dishevelled-associated antagonist of beta-catenin and JNK signaling, is required for notochord formation.
Cheyette BN; Waxman JS; Miller JR; Takemaru K; Sheldahl LC; Khlebtsova N; Fox EP; Earnest T; Moon RT
Dev Cell; 2002 Apr; 2(4):449-61. PubMed ID: 11970895
[TBL] [Abstract][Full Text] [Related]
15. Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level.
Nakamura T; Hamada F; Ishidate T; Anai K; Kawahara K; Toyoshima K; Akiyama T
Genes Cells; 1998 Jun; 3(6):395-403. PubMed ID: 9734785
[TBL] [Abstract][Full Text] [Related]
16. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
Sakanaka C; Weiss JB; Williams LT
Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3020-3. PubMed ID: 9501208
[TBL] [Abstract][Full Text] [Related]
17. A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and beta-catenin.
Thomas GM; Frame S; Goedert M; Nathke I; Polakis P; Cohen P
FEBS Lett; 1999 Sep; 458(2):247-51. PubMed ID: 10481074
[TBL] [Abstract][Full Text] [Related]
18. Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation.
Yuan H; Mao J; Li L; Wu D
J Biol Chem; 1999 Oct; 274(43):30419-23. PubMed ID: 10521419
[TBL] [Abstract][Full Text] [Related]
19. Signaling through beta-catenin and Lef/Tcf.
Novak A; Dedhar S
Cell Mol Life Sci; 1999 Oct; 56(5-6):523-37. PubMed ID: 11212302
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Wnt signaling pathway by a novel axin-binding protein.
Kadoya T; Kishida S; Fukui A; Hinoi T; Michiue T; Asashima M; Kikuchi A
J Biol Chem; 2000 Nov; 275(47):37030-7. PubMed ID: 10944533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
